A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs - The New York Times

1. A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs  The New York Times
2. FDA approves landmark pancreatic cancer drug that's shown to improve survival  wusa9.com
3. Pancreatic cancer drug may hold promise for lung cancer as well, early study suggests  ABC News - Breaking News, Latest News and Videos
4. RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer  biospace.com
5. Newly approved pancreatic cancer drug shows promise in lung cancer  NBC News

from Top stories - Google News https://ift.tt/PoiHEsJ
via Whole story